• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经黑色素敏感磁共振成像对帕金森病患者的诊断性能及异质性的因子分析:系统评价和荟萃分析。

Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis.

机构信息

Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam, Gyeonggi, 13620, Republic of Korea.

Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam, Gyeonggi, 13620, Republic of Korea.

出版信息

Eur Radiol. 2021 Mar;31(3):1268-1280. doi: 10.1007/s00330-020-07240-7. Epub 2020 Sep 4.

DOI:10.1007/s00330-020-07240-7
PMID:32886201
Abstract

OBJECTIVE

To determine the diagnostic performance of neuromelanin-sensitive magnetic resonance imaging discriminating between patients with Parkinson's disease and normal healthy controls and to identify factors causing heterogeneity influencing the diagnostic performance.

METHODS

A systematic literature search in the Ovid-MEDLINE and EMBASE databases was performed for studies reporting the relevant topic before February 17, 2020. The pooled sensitivity and specificity values with their 95% confidence intervals were calculated using bivariate random-effects modeling. Subgroup and meta-regression analyses were also performed to determine factors influencing heterogeneity.

RESULTS

Twelve articles including 403 patients with Parkinson's disease and 298 control participants were included in this systematic review and meta-analysis. Neuromelanin-sensitive magnetic resonance imaging showed a pooled sensitivity of 89% (95% confidence interval, 86-92%) and a pooled specificity of 83% (95% confidence interval, 76-88%). In the subgroup and meta-regression analysis, a disease duration longer than 5 and 10 years, comparisons using measured volumes instead of signal intensities, a slice thickness in terms of magnetic resonance imaging parameters of more than 2 mm, and semi-/automated segmentation methods instead of manual segmentation improved the diagnostic performance.

CONCLUSION

Neuromelanin-sensitive magnetic resonance imaging had a favorable diagnostic performance in discriminating patients with Parkinson's disease from healthy controls. To improve diagnostic accuracy, further investigations directly comparing these heterogeneity-affecting factors and optimizing these parameters are necessary.

KEY POINTS

• Neuromelanin-sensitive MRI favorably discriminates patients with Parkinson's disease from healthy controls. • Disease duration, parameters used for comparison, magnetic resonance imaging slice thickness, and segmentation methods affected heterogeneity across the studies.

摘要

目的

确定神经黑色素敏感磁共振成像在区分帕金森病患者和健康对照组方面的诊断性能,并确定导致影响诊断性能的异质性的因素。

方法

在 2020 年 2 月 17 日之前,对 Ovid-MEDLINE 和 EMBASE 数据库进行了系统的文献检索,以查找报告相关主题的研究。使用双变量随机效应模型计算汇总的敏感性和特异性值及其 95%置信区间。还进行了亚组和荟萃回归分析,以确定影响异质性的因素。

结果

本系统评价和荟萃分析共纳入了 12 篇文章,包括 403 例帕金森病患者和 298 名对照参与者。神经黑色素敏感磁共振成像显示出 89%的汇总敏感性(95%置信区间,86-92%)和 83%的汇总特异性(95%置信区间,76-88%)。在亚组和荟萃回归分析中,疾病持续时间超过 5 年和 10 年、使用测量体积而不是信号强度进行比较、磁共振成像参数中的切片厚度超过 2 毫米、以及半自动/自动分割方法而不是手动分割均提高了诊断性能。

结论

神经黑色素敏感磁共振成像在区分帕金森病患者与健康对照组方面具有良好的诊断性能。为了提高诊断准确性,需要进一步研究直接比较这些影响异质性的因素并优化这些参数。

关键点

• 神经黑色素敏感 MRI 有利于区分帕金森病患者与健康对照组。• 疾病持续时间、用于比较的参数、磁共振成像切片厚度和分割方法影响了研究之间的异质性。

相似文献

1
Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis.神经黑色素敏感磁共振成像对帕金森病患者的诊断性能及异质性的因子分析:系统评价和荟萃分析。
Eur Radiol. 2021 Mar;31(3):1268-1280. doi: 10.1007/s00330-020-07240-7. Epub 2020 Sep 4.
2
Iron-sensitive magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis.铁敏磁共振成像在帕金森病中的应用:系统评价和荟萃分析。
J Neurol. 2021 Dec;268(12):4721-4736. doi: 10.1007/s00415-021-10582-x. Epub 2021 Apr 29.
3
The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.使用 NM-MRI 检测 SNpc 在帕金森病中的诊断价值:荟萃分析。
Neurol Sci. 2019 Dec;40(12):2479-2489. doi: 10.1007/s10072-019-04014-y. Epub 2019 Aug 7.
4
Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.帕金森病患者黑质神经黑色素含量的时空变化。
Brain. 2020 Sep 1;143(9):2757-2770. doi: 10.1093/brain/awaa216.
5
Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.新发帕金森病患者黑质神经黑色素的磁共振成像
Eur J Neurol. 2015 Mar;22(3):540-6. doi: 10.1111/ene.12613. Epub 2014 Dec 22.
6
Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease.帕金森病患者黑质的三维神经黑色素敏感磁共振成像。
Eur J Neurol. 2018 Apr;25(4):680-686. doi: 10.1111/ene.13573. Epub 2018 Feb 8.
7
A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.帕金森病合并多系统萎缩中独特的神经黑色素磁共振成像模式。
BMC Neurol. 2020 Nov 27;20(1):432. doi: 10.1186/s12883-020-02007-5.
8
Comparison of automated and manual quantification methods for neuromelanin-sensitive MRI in Parkinson's disease.帕金森病中神经黑色素敏感 MRI 的自动与手动定量方法比较。
Hum Brain Mapp. 2024 Jan;45(1):e26544. doi: 10.1002/hbm.26544. Epub 2023 Dec 2.
9
Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.自动神经黑素成像作为帕金森病的诊断生物标志物
Mov Disord. 2015 Jun;30(7):945-52. doi: 10.1002/mds.26201. Epub 2015 Mar 15.
10
NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson's disease using convolutional neural network.NigraNet:一种使用卷积神经网络自动评估早期帕金森病黑质神经黑色素含量的框架。
Neuroimage Clin. 2022;36:103250. doi: 10.1016/j.nicl.2022.103250. Epub 2022 Oct 31.

引用本文的文献

1
Early diagnosis of Parkinson's disease: biomarker study.帕金森病的早期诊断:生物标志物研究。
Front Aging Neurosci. 2025 May 9;17:1495769. doi: 10.3389/fnagi.2025.1495769. eCollection 2025.
2
Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry.神经黑色素敏感 MRI 在精神病学中的机制研究和生物标志物开发中的应用。
Neuropsychopharmacology. 2024 Nov;50(1):137-152. doi: 10.1038/s41386-024-01934-y. Epub 2024 Aug 19.
3
Parkinson's image detection and classification based on deep learning.基于深度学习的帕金森病图像检测与分类。

本文引用的文献

1
Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI.基于神经黑色素敏感 MRI 的深度神经网络对帕金森病的预测标志物研究。
Neuroimage Clin. 2019;22:101748. doi: 10.1016/j.nicl.2019.101748. Epub 2019 Mar 6.
2
Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and Parkinson's Disease.利用3T磁共振成像对黑质中黑质小体-1和神经黑色素进行联合可视化以鉴别诊断特发性震颤和帕金森病
Front Neurol. 2019 Feb 12;10:100. doi: 10.3389/fneur.2019.00100. eCollection 2019.
3
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain.
BMC Med Imaging. 2024 Jul 25;24(1):187. doi: 10.1186/s12880-024-01364-8.
4
Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.神经影像学和液体生物标志物在靶向干预时代的帕金森病。
Nat Commun. 2024 Jul 5;15(1):5661. doi: 10.1038/s41467-024-49949-9.
5
Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease.蓝斑及其纤维束的微观结构完整性反映了阿尔茨海默病和帕金森病中的去甲肾上腺素能退行性变。
Transl Neurodegener. 2024 Feb 9;13(1):9. doi: 10.1186/s40035-024-00400-5.
6
Quantitative iron-neuromelanin MRI associates with motor severity in Parkinson's disease and matches radiological disease classification.定量铁-神经黑色素磁共振成像与帕金森病的运动严重程度相关,并与放射学疾病分类相匹配。
Front Aging Neurosci. 2023 Nov 27;15:1287917. doi: 10.3389/fnagi.2023.1287917. eCollection 2023.
7
Comparison of automated and manual quantification methods for neuromelanin-sensitive MRI in Parkinson's disease.帕金森病中神经黑色素敏感 MRI 的自动与手动定量方法比较。
Hum Brain Mapp. 2024 Jan;45(1):e26544. doi: 10.1002/hbm.26544. Epub 2023 Dec 2.
8
Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function.神经黑色素敏感 MRI 作为儿茶酚胺功能有前景的生物标志物。
Brain. 2024 Feb 1;147(2):337-351. doi: 10.1093/brain/awad300.
9
Diagnostic performance of a high-spatial-resolution voxelwise analysis of neuromelanin-sensitive imaging in early-stage idiopathic Parkinson's disease.高空间分辨率体素分析神经黑色素敏感成像在早期特发性帕金森病中的诊断性能。
BMC Med Imaging. 2023 May 18;23(1):64. doi: 10.1186/s12880-023-01018-1.
10
Correlation Between Neuromelanin-Sensitive MRI and F-FP-CIT PET in Early-Stage Parkinson's Disease: Utility of a Voxel-Wise Analysis by Using High-Spatial-Resolution MRI.早期帕金森病中黑质素敏感磁共振成像与F-氟代多巴-羧基-2β-甲酯-3β-(4-碘苯基)托烷正电子发射断层显像的相关性:使用高空间分辨率磁共振成像的体素分析效用
J Clin Neurol. 2023 Mar;19(2):156-164. doi: 10.3988/jcn.2022.0147.
神经黑色素敏感 MRI 作为一种非侵入性的人类大脑多巴胺功能替代测量指标。
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5108-5117. doi: 10.1073/pnas.1807983116. Epub 2019 Feb 22.
4
Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease.帕金森病患者黑质致密部的综合 MRI 定量分析。
Eur J Radiol. 2018 Dec;109:48-56. doi: 10.1016/j.ejrad.2018.06.024. Epub 2018 Oct 28.
5
Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease.黑质神经黑色素敏感 MRI:一种用于区分特发性震颤与震颤为主型帕金森病的影像学生物标志物。
Parkinsonism Relat Disord. 2019 Jan;58:3-8. doi: 10.1016/j.parkreldis.2018.07.007. Epub 2018 Jul 17.
6
Comparative Study of MRI Biomarkers in the Substantia Nigra to Discriminate Idiopathic Parkinson Disease.黑质 MRI 生物标志物在鉴别特发性帕金森病中的比较研究。
AJNR Am J Neuroradiol. 2018 Aug;39(8):1460-1467. doi: 10.3174/ajnr.A5702. Epub 2018 Jun 28.
7
The utility of the combined use of I-FP-CIT SPECT and neuromelanin MRI in differentiating Parkinson's disease from other parkinsonian syndromes.I-FP-CIT单光子发射计算机断层扫描(SPECT)与神经黑色素磁共振成像(MRI)联合应用在鉴别帕金森病与其他帕金森综合征中的效用。
Acta Radiol. 2019 Feb;60(2):230-238. doi: 10.1177/0284185118778871. Epub 2018 May 27.
8
Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.神经黑色素成像与中脑体积测量在进行性核上性麻痹和帕金森病中的应用。
Mov Disord. 2018 Sep;33(9):1488-1492. doi: 10.1002/mds.27365. Epub 2018 May 14.
9
Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.使用定量磁化率成像和神经黑色素成像对黑质小体变化进行定量分析以诊断早期帕金森病。
Br J Radiol. 2018 Jun;91(1086):20180037. doi: 10.1259/bjr.20180037. Epub 2018 May 17.
10
Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease.帕金森病患者黑质的三维神经黑色素敏感磁共振成像。
Eur J Neurol. 2018 Apr;25(4):680-686. doi: 10.1111/ene.13573. Epub 2018 Feb 8.